# Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection

> **NCT02973646** · PHASE4 · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Hepatitis b

## Interventions

- **DRUG:** Entecavir or Tenofovir
- **DRUG:** Peginterferon Alfa-2B

## Key facts

- **NCT ID:** NCT02973646
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973646, "Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02973646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*